CLPT ClearPoint Neuro Inc.

Building on the imaging power of MRI, ClearPoint Neuro is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The company's ClearPoint® system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing MRI suite to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, ClearPoint Neuro is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.

$23.48  +0.06 (0.26%)
As of 03/01/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Medical Devices
USA
USA
07/13/2000
19,465,213
502,169
$457,043,201
0.00%
SEC Edgar Online
10-Q
10-K
18507C103
US18507C1036
BKT1TK6

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-66.76
3,065.35
37.09
-4,591.42%
-55.55%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy